The size of the Europe Cellular Health Screening Market was worth USD 0.7 billion in 2020 and estimated to be growing at a CAGR of 9.57% to reach USD 1.11 billion by 2025.
Cellular Health Screening is a revolutionary technology by which an overview of a patient’s health can be quickly obtained at a cellular level. It tells how well the cells of a patient are functioning and indicates how well the body is working as a whole. Also, the areas which need support and development can be identified best-individualized treatment plan can be known to get the best results. Progress can also be monitored throughout the treatment and provide the patient with detailed reports so that the patient can see the improvement on a cellular level at each step of the way.
Cellular health screening is ideal for anyone who needs a general check-up or would like to get a better picture of their health. It can assess inflammatory conditions, such as allergies, asthma, autoimmune conditions, arthritis, or inflammatory digestive problems. It can also be used to monitor response to the treatment given. Overall cellular health can also be clearly understood, including biomarkers for aging and body composition, which makes this technology ideal to assess and monitor patients who may need to detoxify, lose excess body fat or develop a long term strategy for healthy aging.
The driving factors of Europe Cellular Health Screening market are growing adoption of telomere performance programs for leading a healthy life, the rising importance of healthy life expectancy, rising government focus towards preventive healthcare, growing geriatric population and the resultant growth in the need for cellular health screening, increasing research activities, increasing adoption of the direct-to-consumer approach and the growing burden of chronic diseases among others. However, the market is constrained by factors such as problems associated with the transport of samples and differences in the cost of test kits offered by different companies.
This research report has been segmented and sub-segmented into the following categories:
By Test Panels Type:
By Sample Type:
By Sample Collection Site:
By Country:
Regionally, Europe has the second-largest market for cellular health diagnostics in the world by share. Factors such as rising importance for higher life expectancy and rising geriatric population are expected to drive the market growth during the forecast period.
Key market participants dominating the European Cellular Health Diagnostics Market profiled in this report are Genova Diagnostics (U.S.), Quest Diagnostics (U.S.), Telomere Diagnostics (U.S.), Life Length (Spain), Repeat Diagnostics (Canada), SpectraCell Laboratories (U.S.), Zimetry LLC (U.S.), Cell Science Systems (U.S.), Titanovo, Inc. (U.S.), Segterra, Inc. (U.S.), LabCorp Holdings (U.S.), BioReference Laboratories (U.S.), Immundiagnostik AG (Germany), and Cleveland HeartLab, Inc. (U.S.).
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Single Test Panels
5.1.1.1 Telomere Tests
5.1.1.2 Inflammation Tests
5.1.1.3 Oxidative Stress Tests
5.1.1.4 Heavy Metal Tests
5.1.2 Multi Test Panels
5.1.3 Y-o-Y Growth Analysis, By Type
5.1.4 Market Attractiveness Analysis, By Type
5.1.5 Market Share Analysis, By Type
5.2 Sample Type
5.2.1 Blood Samples
5.2.2 Other Samples
5.2.3 Y-o-Y Growth Analysis, By Sample Type
5.2.4 Market Attractiveness Analysis, By Sample Type
5.2.5 Market Share Analysis, By Sample Type
5.3 Sample Collection Site
5.3.1 In-Office Sample Collection
5.3.2 At-Home Sample Collection
5.3.3 Other Sample Collections
5.3.4 Y-o-Y Growth Analysis, By Sample Collection Site
5.3.5 Market Attractiveness Analysis, By Sample Collection Site
5.3.6 Market Share Analysis, By Sample Collection Site
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Type
6.1.3.2 By Sample Type
6.1.3.3 By Sample Collection Site
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Type
6.1.4.2 By Sample Type
6.1.4.3 By Sample Collection Site
6.1.5 Market Share Analysis
6.1.5.1 By Type
6.1.5.2 By Sample Type
6.1.5.3 By Sample Collection Site
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Genova Diagnostics
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Quest Diagnostics
8.3 Telomere Diagnostics
8.4 Life Length
8.5 Repeat Diagnostics
8.6 SpectraCell Laboratories
8.7 Zimetry LLC
8.8 Cell Science Systems
8.9 Titanovo, Inc.
8.10 Segterra, Inc.
8.11 LabCorp Holdings
8.12 BioReference Laboratories
8.13 Immundiagnostik AG
8.14 Cleveland HeartLab, Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
Download Sample
